Patexia - Pfizer vs Teva was a big case between generic and brand drugmakers, and was the first time when damages were paid for the creation and selling of a generic brand
Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer's Kindler KO'd by Teva's Yanai
Pfizer is releasing a generic Viagra as its patent expires — Quartz
Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout | Reuters.com
Pfizer Wins Lyrica Patent Infringement Case Against Teva and Other Generic Drug Manufacturers | American University Intellectual Property Brief
Israel's Teva, more than 30 other firms worldwide to start making Pfizer's COVID pill - Israel News - Haaretz.com
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Pfizer and Teva face new drug delay action - Global Competition Review
Pfizer links with Synthon on generic Copaxone - PMLiVE
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
Israeli study finds major drop in symptomatic COVID-19 cases with Pfizer vaccine | CBC News
Vincristine shortage - Teva Pharmaceuticals promises help | 11alive.com
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | Fierce Pharma
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | Fierce Pharma
Teva to enter Lipitor generic market - Pharmaceutical Technology
Pfizer and Regeneron led pharma's sales growth in Q4 while Teva, Biogen and Gilead lagged | Fierce Pharma
Pfizer to settle Xeljanz suit with Teva
Teva Pharmaceuticals, 20 others accused of illegal drug price hikes
